Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer A Strople

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2024
Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel DiseaseErica J Brenner, Kimberly N Weaver, Xian Zhang, et al.
The American Journal of Gastroenterology|September 17, 2022
Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel DiseaseArthur J Kastl, Kimberly N Weaver, Xian Zhang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 24, 2024
Travel Time to Treating Center Is Associated With Diagnostic Delay in Pediatric Inflammatory Bowel DiseaseJoi F McLaughlin, Tiffany Linville, Traci W Jester, et al.
The American Journal of Gastroenterology|October 18, 2024
HLA DQA1*05 and risk of anti-TNF treatment failure and anti-drug antibody development in children with Crohn's Disease: HLA DQA1*05 and Pediatric Crohn's DiseaseJeremy Adler, Joseph A Galanko, Rana Ammoury, et al.
The American Journal of Gastroenterology|May 2, 2025
HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's DiseaseJeremy Adler, Joseph A Galanko, Rana Ammoury, et al.
EGEMS (Washington, DC)|October 25, 2019
Implementing a Novel Quality Improvement-Based Approach to Data Quality Monitoring and Enhancement in a Multipurpose Clinical RegistryJesse Pratt, Daniel Jeffers, Eileen C King, et al.
Inflammatory Bowel Diseases|October 17, 2024
Low Anti-Tumor Necrosis Factor Levels During Maintenance Phase Are Associated With Treatment Failure in Children With Crohn's DiseaseJonathan Moses, Jeremy Adler, Shehzad A Saeed, et al.
Gastroenterology|April 2, 2023
Comparative Effectiveness of Anti-TNF in Combination With Low-Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: A Pragmatic Randomized TrialMichael D Kappelman, David A Wohl, Hans H Herfarth, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 18, 2024
Long-Term Effectiveness and Durability of COVID-19 Vaccination Among Patients With Inflammatory Bowel DiseaseErica J Brenner, Kimberly N Weaver, Xian Zhang, et al.
The American Journal of Gastroenterology|September 17, 2022
Humoral Immune Response and Safety of SARS-CoV-2 Vaccination in Pediatric Inflammatory Bowel DiseaseArthur J Kastl, Kimberly N Weaver, Xian Zhang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|August 24, 2024
Travel Time to Treating Center Is Associated With Diagnostic Delay in Pediatric Inflammatory Bowel DiseaseJoi F McLaughlin, Tiffany Linville, Traci W Jester, et al.
The American Journal of Gastroenterology|October 18, 2024
HLA DQA1*05 and risk of anti-TNF treatment failure and anti-drug antibody development in children with Crohn's Disease: HLA DQA1*05 and Pediatric Crohn's DiseaseJeremy Adler, Joseph A Galanko, Rana Ammoury, et al.
The American Journal of Gastroenterology|May 2, 2025
HLA DQA1*05 and Risk of Antitumor Necrosis Factor Treatment Failure and Anti-Drug Antibody Development in Children With Crohn's DiseaseJeremy Adler, Joseph A Galanko, Rana Ammoury, et al.
EGEMS (Washington, DC)|October 25, 2019
Implementing a Novel Quality Improvement-Based Approach to Data Quality Monitoring and Enhancement in a Multipurpose Clinical RegistryJesse Pratt, Daniel Jeffers, Eileen C King, et al.
Inflammatory Bowel Diseases|October 17, 2024
Low Anti-Tumor Necrosis Factor Levels During Maintenance Phase Are Associated With Treatment Failure in Children With Crohn's DiseaseJonathan Moses, Jeremy Adler, Shehzad A Saeed, et al.
Gastroenterology|April 2, 2023
Comparative Effectiveness of Anti-TNF in Combination With Low-Dose Methotrexate vs Anti-TNF Monotherapy in Pediatric Crohn's Disease: A Pragmatic Randomized TrialMichael D Kappelman, David A Wohl, Hans H Herfarth, et al.
Pageof 2